These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3953818)
1. Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Gores GJ; LaRusso NF; Miller LJ Am J Physiol; 1986 Mar; 250(3 Pt 1):G344-9. PubMed ID: 3953818 [TBL] [Abstract][Full Text] [Related]
2. Hepatic processing of cholecystokinin peptides. II. Cellular metabolism, transport, and biliary excretion. Gores GJ; Miller LJ; LaRusso NF Am J Physiol; 1986 Mar; 250(3 Pt 1):G350-6. PubMed ID: 3953819 [TBL] [Abstract][Full Text] [Related]
3. Processing of cholecystokinin by isolated liver cells. Gores GJ; Kost LJ; Miller LJ; LaRusso NF Am J Physiol; 1989 Aug; 257(2 Pt 1):G242-8. PubMed ID: 2764109 [TBL] [Abstract][Full Text] [Related]
4. Physicochemical determinants in hepatic extraction of small peptides. Hunter EB; Powers SP; Kost LJ; Pinon DI; Miller LJ; LaRusso NF Hepatology; 1990 Jul; 12(1):76-82. PubMed ID: 2373488 [TBL] [Abstract][Full Text] [Related]
5. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [TBL] [Abstract][Full Text] [Related]
6. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors. Schäfer U; Harhammer R; Boomgaarden M; Sohr R; Ott T; Henklein P; Repke H J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated. Pearson RK; Hadac EM; Miller LJ Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263 [TBL] [Abstract][Full Text] [Related]
8. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides. Vinayek R; Jensen RT; Gardner JD Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164 [TBL] [Abstract][Full Text] [Related]
10. High affinity binding of cholecystokinin to small cell lung cancer cells. Yoder DG; Moody TW Peptides; 1987; 8(1):103-7. PubMed ID: 3033616 [TBL] [Abstract][Full Text] [Related]
11. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels. Jansen JB; Lamers CB J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353 [TBL] [Abstract][Full Text] [Related]
12. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702. Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411 [TBL] [Abstract][Full Text] [Related]
13. Sulfation of tert-butoxycarbonylcholecystokinin and other peptides by rat liver tyrosylprotein sulfotransferase. Rens-Domiano S; Hortin GL; Roth JA Mol Pharmacol; 1989 Oct; 36(4):647-53. PubMed ID: 2811860 [TBL] [Abstract][Full Text] [Related]
14. Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide. Beckh K; Dirks A; Koop I; Koop H; Adler G Res Exp Med (Berl); 1997; 197(3):125-35. PubMed ID: 9406280 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. Pearson RK; Miller LJ; Hadac EM; Powers SP J Biol Chem; 1987 Oct; 262(28):13850-6. PubMed ID: 3654639 [TBL] [Abstract][Full Text] [Related]
16. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors. Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251 [TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Povoski SP; Zhou W; Longnecker DS; Bell RH Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527 [TBL] [Abstract][Full Text] [Related]